Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation.
about
Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?In vitro evaluation of clot quality and stability in a model of severe thrombocytopenia: effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitorAddition of a sequence from alpha2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysisFactor XIII Deficiency and Thrombocytopenia Are Frequent Modulators of Postoperative Clot Firmness in a Surgical Intensive Care Unit.Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites.Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa.Current understanding in diagnosis and management of factor XIII deficiency.Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysisFactor XIII--an under diagnosed deficiency--are we using the right assays?A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor.
P2860
Q27026565-2A8F21F7-42B3-46FC-8FAE-4B71E24D8CB2Q33412076-A30BB59E-BDEC-4045-9DA2-CD15E80884BAQ33414424-60F5328A-4C01-4D64-87B9-8EFF9A762E1DQ33441826-A4653E53-88CE-4EE0-A460-67285929DD1FQ34101596-5EA3BDB0-08B5-4D26-B58E-7CB94AEA0485Q34107034-25CEE051-3599-41D8-8BF7-FAEE23BEDA53Q37560127-436679E9-15E2-4A91-BCD6-461C9B35B2F3Q37899674-59180A5D-C445-43F0-9EFA-2E1EC2DA26AEQ41904806-DDF8ADEF-447C-4B90-90B9-7AC099EF07B3Q42931085-77053C55-E29C-49AD-BA6A-D29D840D8E8FQ45973915-0CF0F1C4-FEF5-494E-A677-1FC5651C9E1B
P2860
Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Evidence that alpha2-antiplasm ...... II in fibrinolysis regulation.
@en
type
label
Evidence that alpha2-antiplasm ...... II in fibrinolysis regulation.
@en
prefLabel
Evidence that alpha2-antiplasm ...... II in fibrinolysis regulation.
@en
P2093
P2860
P1476
Evidence that alpha2-antiplasm ...... II in fibrinolysis regulation.
@en
P2093
I Hernandez
K R Siebenlist
M W Mosesson
V J Christiansen
P2860
P304
P356
10.1111/J.1538-7836.2008.03056.X
P577
2008-06-16T00:00:00Z